Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Critical Outcome Technologies reports preclinical data on oral COTI-2 in TNBC model

April 1, 2010

YM BioSciences expands ongoing phase I/II CYT-387 study in myelofibrosis

April 1, 2010

NexMed files IND with FDA for phase II trial of PrevOnco in hepatocellular carcinoma

April 1, 2010

Eisai submits anticancer agent eribulin for approval in Japan, U.S. and Europe

April 1, 2010

SciClone reports topline phase II data on SCV-07 for prevention of oral mucositis

April 1, 2010

Emory University claims new noscapine analogues for cancer therapy

April 1, 2010

MMRF grants awards to Intellikine and Tragara for multiple myeloma therapies

March 31, 2010

Immunovaccine Technologies begins enrollment in phase I trial of DPX-0907 cancer vaccine

March 31, 2010

GSK resubmits Avodart sNDA for prostate cancer to FDA

March 31, 2010

Syngene to collaborate with Endo to develop anticancer molecules

March 31, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...